NIPT, or non-invasive prenatal testing, is a test used to detect chromosomal abnormalities in a fetus. It may be used to detect Down syndrome, trisomy 13, trisomy 18, and some sex chromosome abnormalities. However, Angelman syndrome is not typically detectable through NIPT.
Angelman syndrome is a genetic disorder caused by a defect in the UBE3A gene. It is usually caused by a deletion of the maternal copy of the UBE3A gene or by a mutation of the mother's UBE3A gene. Because NIPT tests for chromosomal abnormalities, and Angelman syndrome is caused by a gene mutation, it is not detectable in NIPT.
Although Angelman syndrome is not detectable through NIPT, it can be detected through other tests. Genetic testing can be used to identify the presence of Angelman syndrome. In this test, a small sample of blood or saliva is taken and analyzed to detect any gene mutations that may be responsible for the condition. This test can be performed on the mother, the father, or the fetus itself. In addition, a few other tests can be used to make the diagnosis of Angelman syndrome, including EEGs, MRIs, and other neurological tests.
In conclusion, Angelman syndrome is not typically detectable through NIPT. However, there are other tests that can be used to diagnose the condition.